Melatonin attenuates prenatal dexamethasone-induced blood pressure increase in a rat model

Journal of the American Society of Hypertension

Volumn 8, Issue 4, 2014, Pages 216-226

  Tain, You Lin ^a,b   Chen, Chih Cheng ^a   Sheen, Jiunn Ming ^a   Yu, Hong Ren ^a   Tiao, Mao Meng ^a   Kuo, Ho Chang ^a   Huang, Li Tung ^a,b  

^a CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

^b CHANG GUNG UNIVERSITY   (Taiwan)

Author keywords

Asymmetric dimethylarginine; histone deacetylase; hypertension; melatonin; oxidative stress; renin angiotensin system

Indexed keywords

6 N N DIMETHYLARGININE; ARGININE; CITRULLINE; DEXAMETHASONE; DRINKING WATER; HISTONE DEACETYLASE 1; HISTONE DEACETYLASE 2; HISTONE DEACETYLASE 8; MELATONIN; N(G),N(G) DIMETHYLARGININE; NITRIC OXIDE; PRORENIN RECEPTOR; RENIN; SUPEROXIDE; UNCLASSIFIED DRUG; CELL SURFACE RECEPTOR; G PROTEIN COUPLED RECEPTOR; HISTONE DEACETYLASE; MESSENGER RNA; ONCOPROTEIN; PROTO-ONCOGENE PROTEINS C-MAS-1;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD LEVEL; BLOOD PRESSURE MEASUREMENT; CONTROLLED STUDY; DRUG EXPOSURE; FEMALE; GENE EXPRESSION; HYPERTENSION; LACTATION; MALE; NEPHRON; NONHUMAN; PREGNANCY; PRENATAL EXPOSURE; PRIORITY JOURNAL; RAT; UPREGULATION; ADVERSE EFFECTS; ANIMAL; CHEMICALLY INDUCED; MATERNAL EXPOSURE; METABOLISM; REAL TIME POLYMERASE CHAIN REACTION; SPRAGUE DAWLEY RAT; WESTERN BLOTTING;

ANIMALS; BLOTTING, WESTERN; DEXAMETHASONE; FEMALE; HISTONE DEACETYLASES; HYPERTENSION; MATERNAL EXPOSURE; MELATONIN; NITRIC OXIDE; PREGNANCY; PRENATAL EXPOSURE DELAYED EFFECTS; PROTO-ONCOGENE PROTEINS; RATS; RATS, SPRAGUE-DAWLEY; REAL-TIME POLYMERASE CHAIN REACTION; RECEPTORS, CELL SURFACE; RECEPTORS, G-PROTEIN-COUPLED; RENIN; RNA, MESSENGER; SUPEROXIDES;

EID: 84898630654     PISSN: 19331711     EISSN: 18787436     Source Type: Journal    
DOI: 10.1016/j.jash.2014.01.009     Document Type: Article

References (32)

1. S.E. Ozanne, and M. Constância Mechanisms of disease: the developmental origins of disease and the role of the epigenotype Nat Clin Pract Endocrinol Metab 3 2007 539 546
2. D. Roberts, and S. Dalziel Antenatal corticosteroids for accelerating fetal lung maturation for women at risk of preterm birth Cochrane Database Syst Rev 3 2006 CD004454
3. L.A. Ortiz, A. Quan, F. Zarzar, A. Weinberg, and M. Baum Prenatal dexamethasone programs hypertension and renal injury in the rat Hypertension 41 2003 328 334
4. N.B. Ojeda, D. Grigore, and B.T. Alexander Developmental programming of hypertension: insight from animal models of nutritional manipulation Hypertension 52 2008 44 50
5. Y.L. Tain, and L.T. Huang Asymmetric dimethylarginine: Clinical applications in pediatric medicine J Formos Med Assoc 110 2011 70 77
6. Y.L. Tain, C.S. Hsieh, I.C. Lin, C.C. Chen, J.M. Sheen, and L.T. Huang Effects of maternal L-citrulline supplementation on renal function and blood pressure in offspring exposed to maternal caloric restriction: the impact of nitric oxide pathway Nitric Oxide 23 2010 34 41
7. Y.L. Tain, W.C. Lee, C.N. Hsu, W.C. Lee, L.T. Huang, and C.T. Lee et al. Asymmetric dimethylarginine is associated with developmental programming of adult kidney disease and hypertension in offspring of streptozotocin-treated mothers PLoS ONE 8 2013 e55420
8. I. Bogdarina, S. Welham, P.J. King, S.P. Burns, and A.J. Clark Epigenetic modification of the renin-angiotensin system in the fetal programming of hypertension Circ Res 100 2007 520 526
9. S. Chen, C. Bellew, X. Yao, J. Stefkova, S. Dipp, and Z. Saifudeen et al. Histone deacetylase (HDAC) activity is critical for embryonic kidney gene expression, growth, and differentiation J Biol Chem 286 2011 32775 32789
10. D.X. Tan, L.C. Manchester, M.P. Terron, L.J. Flores, and R.J. Reiter One molecule, many derivatives: a never-ending interaction of melatonin with reactive oxygen and nitrogen species? J Pineal Res 42 2007 28 42
11. F.A. Scheer Potential use of melatonin as adjunct antihypertensive therapy Am J Hypertens 18 2005 1619 1620
12. R.J. Reiter, D.X. Tan, and A. Korkmaz The circadian melatonin rhythm and its modulation: possible impact on hypertension J Hypertens 27 Suppl 6 2009 S17 S20
13. Y.L. Tain, L.T. Huang, I.C. Lin, Y.T. Lau, and C.Y. Lin Melatonin prevents hypertension and increased asymmetric dimethylarginine in young spontaneous hypertensive rats J Pineal Res 49 2010 390 398
14. M. Erşahin, O. Sehirli, H.Z. Toklu, S. Süleymanoglu, E. Emekli-Alturfan, and A. Yarat et al. Melatonin improves cardiovascular function and ameliorates renal, cardiac and cerebral damage in rats with renovascular hypertension J Pineal Res 47 2009 97 106
15. R. Sharma, T. Ottenhof, P.A. Rzeczkowska, and L.P. Niles Epigenetic targets for melatonin: induction of histone H3 hyperacetylation and gene expression in C17.2 neural stem cells J Pineal Res 45 2008 277 284
16. A. Korkmaz, S. Rosales-Corral, and R.J. Reiter Gene regulation by melatonin linked to epigenetic phenomena Gene 503 2012 1 11
17. B. Jung-Hynes, R.J. Reiter, and N. Ahmad Sirtuins, melatonin and circadian rhythms: building a bridge between aging and cancer J Pineal Res 48 2010 9 19
18. R. Nagai, K. Watanabe, A. Wakatsuki, F. Hamada, K. Shinohara, and Y. Hayashi et al. Melatonin preserves fetal growth in rats by protecting against ischemia/reperfusion-induced oxidative/nitrosative mitochondrial damage in the placenta J Pineal Res 45 2008 271 276
19. Y.C. Chen, J.M. Sheen, M.M. Tiao, Y.L. Tain, and L.T. Huang Roles of melatonin in fetal programming in compromised pregnancies Int J Mol Sci 14 2013 5380 5401
20. J.I. Tang, C.J. Kenyon, J.R. Seckl, and M.J. Nyirenda Prenatal overexposure to glucocorticoids programs renal 11β-hydroxysteroid dehydrogenase type 2 expression and salt-sensitive hypertension in the rat J Hypertens 29 2011 282 289
21. J.R. Seckl, and M.C. Holmes Mechanisms of disease: glucocorticoids, their placental metabolism and fetal 'programming' of adult pathophysiology Nat Clin Pract Endocrinol Metab 3 2007 479 488
22. H. Dickinson, D.W. Walker, E.M. Wintour, and K. Moritz Maternal dexamethasone treatment at midgestation reduces nephron number and alters renal gene expression in the fetal spiny mouse Am J Physiol Regul Integr Comp Physiol 292 2007 R453 R461
23. A.K. Abdel-Hakeem, T.Q. Henry, T.R. Magee, M. Desai, M.G. Ross, and R.Z. Mansano et al. Mechanisms of impaired nephrogenesis with fetal growth restriction: altered renal transcription and growth factor expression Am J Obstet Gynecol 199 2008 252.e1 252.e7
24. C.S. Wilcox Oxidative stress and nitric oxide deficiency in the kidney: a critical link to hypertension? Am J Physiol Regul Integr Comp Physiol 289 2005 R913 R935
25. S. Racasan, B. Braam, H.A. Koomans, and J.A. Joles Programming blood pressure in adult SHR by shifting perinatal balance of NO and reactive oxygen species toward NO: the inverted Barker phenomenon Am J Physiol Renal Physiol 288 2005 F626 F636
26. C.N. Hsu, L.T. Huang, Y.T. Lau, C.Y. Lin, and Y.L. Tain The combined ratios of L-arginine, asymmetric and symmetric dimethylarginine as biomarkers in spontaneously hypertensive rats Transl Res 159 2012 90 98
27. V.M. Vehaskari, T. Stewart, D. Lafont, C. Soyez, D. Seth, and J. Manning Kidney angiotensin and angiotensin receptor expression in prenatally programmed hypertension Am J Physiol Renal Physiol 287 2004 F262 F267
28. R. Goyal, D. Goyal, A. Leitzke, C.P. Gheorghe, and L.D. Longo Brain renin-angiotensin system: fetal epigenetic programming by maternal protein restriction during pregnancy Reprod Sci 17 2010 227 238
29. R. Song, and I.V. Yosypiv (Pro)renin Receptor in Kidney Development and Disease Int J Nephrol 2011 2011 247048
30. W.G. Deng, S.T. Tang, H.P. Tseng, and K.K. Wu Melatonin suppresses macrophage cyclooxygenase-2 and inducible nitric oxide synthase expression by inhibiting p52 acetylation and binding Blood 108 2006 518 524
31. R. Song, T. Van Buren, and I.V. Yosypiv Histone deacetylases are critical regulators of the renin-angiotensin system during ureteric bud branching morphogenesis Pediatr Res 67 2010 573 578
32. H.J. Singh, L.S. Keah, A. Kumar, and K.N. Sirajudeen Adverse effects of melatonin on rat pups of Wistar-Kyoto dams receiving melatonin supplementation during pregnancy Exp Toxicol Pathol 64 2012 751 752